Literature DB >> 29948426

Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes.

Karel Souček1,2, Alice Malenovská3, Zuzana Kahounová4,5, Ján Remšík4,5,6, Zuzana Holubcová3,7, Tomáš Soukup8, Daniela Kurfürstová9, Jan Bouchal9, Tereza Suchánková4, Eva Slabáková4, Aleš Hampl10,11.   

Abstract

PURPOSE: The purpose of the study was to determine whether the GDF-15 is present in follicular fluid; to evaluate if there is a relation between follicular and serum levels of GDF-15 and fertility status of study subjects; and to test whether granulosa cells, oocytes, or both produce GDF-15.
METHODS: This study used follicular fluid (FF, serum, and oocytes obtained under informed consent from women undergoing oocyte retrieval for in vitro fertilization. It also used ovaries from deceased preterm newborns. Collection of FF and blood at the time of oocyte retrieval, ELISA and western blot were performed to determine levels and forms of GDF-15. Concentrations of GDF-15 in FF and serum, its expression in ovarian tissue, and secretion from granulosa cells were analyzed.
RESULTS: GDF-15 concentration in FF ranged from 35 to 572 ng/ml, as determined by ELISA. Western blot analysis revealed the GDF-15 pro-dimer only in FF. Both normal healthy and cancerous granulosa cells secreted GDF-15 into culture media. Primary oocytes displayed cytoplasmic GDF-15 positivity in immunostained newborn ovaries, and its expression was also observed in fully grown human oocytes.
CONCLUSIONS: To the best of our knowledge, this is the first documentation of cytokine GDF-15 presence in follicular fluid. Its concentration was not associated with donor/patient fertility status. Our data also show that GDF-15 is expressed and inducible in both normal healthy and cancerous granulosa cells, as well as in oocytes.

Entities:  

Keywords:  Follicular fluid; Follicular granulosa cells; Growth/differentiation factor-15; IVF

Mesh:

Substances:

Year:  2018        PMID: 29948426      PMCID: PMC6086784          DOI: 10.1007/s10815-018-1230-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  46 in total

1.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

2.  GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.

Authors:  Linda Yang; Chih-Chuan Chang; Zhe Sun; Dennis Madsen; Haisun Zhu; Søren B Padkjær; Xiaoai Wu; Tao Huang; Karin Hultman; Sarah J Paulsen; Jishu Wang; Anne Bugge; Jane Boesen Frantzen; Per Nørgaard; Jacob Fuglsbjerg Jeppesen; Zhiru Yang; Anna Secher; Haibin Chen; Xun Li; Linu Mary John; Bing Shan; Zhenhua He; Xiang Gao; Jing Su; Kristian T Hansen; Wei Yang; Sebastian Beck Jørgensen
Journal:  Nat Med       Date:  2017-08-28       Impact factor: 53.440

Review 3.  Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.

Authors:  V W W Tsai; S Lin; D A Brown; A Salis; S N Breit
Journal:  Int J Obes (Lond)       Date:  2015-12-01       Impact factor: 5.095

4.  Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Authors:  Lars Wallentin; Ziad Hijazi; Ulrika Andersson; John H Alexander; Raffaele De Caterina; Michael Hanna; John D Horowitz; Elaine M Hylek; Renato D Lopes; Signild Asberg; Christopher B Granger; Agneta Siegbahn
Journal:  Circulation       Date:  2014-10-07       Impact factor: 29.690

5.  The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.

Authors:  Asne R Bauskin; David A Brown; Simon Junankar; Krishan K Rasiah; Sarah Eggleton; Mark Hunter; Tao Liu; Dave Smith; Tamara Kuffner; Greg J Pankhurst; Heiko Johnen; Pamela J Russell; Wade Barret; Phillip D Stricker; John J Grygiel; James G Kench; Susan M Henshall; Robert L Sutherland; Samuel N Breit
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  Correlation of serum anti-Mullerian hormone to follicular follicle stimulating hormone and implantation potential of the ensuing embryos.

Authors:  Maw-Sheng Lee; Shu-Ling Tzeng; Shun-Fa Yang; Yi-Ping Lin; En-Hui Cheng; Chun-Chia Huang; Yu-Shih Yang; Tsung-Hsien Lee
Journal:  Clin Chim Acta       Date:  2017-07-03       Impact factor: 3.786

7.  Obesity and time to pregnancy.

Authors:  D C Gesink Law; R F Maclehose; M P Longnecker
Journal:  Hum Reprod       Date:  2006-11-09       Impact factor: 6.918

8.  Follicular fluid and serum levels of inhibin A and pregnancy-associated plasma protein A in patients undergoing IVF.

Authors:  Jiri Moos; Vanda Filova; Jana Pavelkova; Martina Moosova; Jana Peknicova; Karel Rezabek
Journal:  Fertil Steril       Date:  2008-04-01       Impact factor: 7.329

Review 9.  Concise review: growth differentiation factor 15 in pathology: a clinical role?

Authors:  Jill Corre; Benjamin Hébraud; Philippe Bourin
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

10.  Growth/differentiation factor 15 promotes EGFR signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice.

Authors:  Carmen Carrillo-García; Sebastian Prochnow; Ina K Simeonova; Jens Strelau; Gabriele Hölzl-Wenig; Claudia Mandl; Klaus Unsicker; Oliver von Bohlen Und Halbach; Francesca Ciccolini
Journal:  Development       Date:  2014-02       Impact factor: 6.868

View more
  3 in total

1.  Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort.

Authors:  Paul Welsh; Dorien M Kimenai; Riccardo E Marioni; Caroline Hayward; Archie Campbell; David Porteous; Nicholas L Mills; Stephen O'Rahilly; Naveed Sattar
Journal:  Clin Chem Lab Med       Date:  2022-08-18       Impact factor: 8.490

2.  Screening of Cellular Stress Responses Induced by Ambient Aerosol Ultrafine Particle Fraction PM0.5 in A549 Cells.

Authors:  Pavlína Šimečková; Soňa Marvanová; Pavel Kulich; Lucie Králiková; Jiří Neča; Jiřina Procházková; Miroslav Machala
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

3.  Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages.

Authors:  Pavlína Šimečková; František Hubatka; Jan Kotouček; Pavlína Turánek Knötigová; Josef Mašek; Josef Slavík; Ondrej Kováč; Jiří Neča; Pavel Kulich; Dominik Hrebík; Jana Stráská; Kateřina Pěnčíková; Jiřina Procházková; Pavel Diviš; Stuart Macaulay; Robert Mikulík; Milan Raška; Miroslav Machala; Jaroslav Turánek
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.